MAPK14 and Parkinson disease: A transgenic PD mouse model based on mutant α-synuclein expression presented with activation of p38, which phosphorylates Parkin-1 and promotes mitochondrial dysfunction and DA neuron loss (Chen et al., 2018) (Figure 5E).